Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptional regulation of KCNA2 coding Kv1.2 by EWS::FLI1: involvement in controlling the YAP/Hippo signalling pathway and cell proliferation.
Dupuy M, Postec A, Mullard M, Chantôme A, Hulin P, Brion R, Gueguinou M, Regnier L, Potier-Cartereau M, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: gueguinou m. Cell Commun Signal. 2024 Dec 18;22(1):602. doi: 10.1186/s12964-024-01981-4. Cell Commun Signal. 2024. PMID: 39695664 Free PMC article.
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, Regnier L, Amiaud J, Hubsch C, Potier-Cartereau M, Chantôme A, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Entz-Werlé N, Delattre O, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: gueguinou m. Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03199-7. Online ahead of print. Oncogene. 2024. PMID: 39487324
MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development.
Robert A, Crottès D, Bourgeais J, Gueguen N, Chevrollier A, Dumas JF, Servais S, Domingo I, Chadet S, Sobilo J, Hérault O, Lecomte T, Vandier C, Raoul W, Guéguinou M. Robert A, et al. Among authors: gueguinou m. PLoS Biol. 2024 Oct 28;22(10):e3002854. doi: 10.1371/journal.pbio.3002854. eCollection 2024 Oct. PLoS Biol. 2024. PMID: 39466877 Free PMC article.
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. Proteau S, et al. Among authors: gueguinou m. EMBO Mol Med. 2024 Sep;16(9):2262-2267. doi: 10.1038/s44321-024-00114-1. EMBO Mol Med. 2024. PMID: 39164473 Free PMC article.
Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer.
Chautard R, Caulet M, Bouché O, Borg C, Manfredi S, Capitain O, Spano JP, Raoul W, Guéguinou M, Herault O, Ferru A, Pobel C, Sire O, Lecomte T. Chautard R, et al. Among authors: gueguinou m. Dig Liver Dis. 2024 Aug 19:S1590-8658(24)00886-7. doi: 10.1016/j.dld.2024.07.022. Online ahead of print. Dig Liver Dis. 2024. PMID: 39164167 Free article.
Understanding natural isotopic variations in cultured cancer cells.
Mantha OL, Mahé M, Mahéo K, Fromont G, Guéguinou M, Tea I, Hankard R, De Luca A. Mantha OL, et al. Among authors: gueguinou m. Rapid Commun Mass Spectrom. 2024 Oct 15;38(19):e9878. doi: 10.1002/rcm.9878. Rapid Commun Mass Spectrom. 2024. PMID: 39117991
Endogenous ether lipids differentially promote tumor aggressiveness by regulating the SK3 channel.
Papin M, Fontaine D, Goupille C, Figiel S, Domingo I, Pinault M, Guimaraes C, Guyon N, Cartron PF, Emond P, Lefevre A, Gueguinou M, Crottès D, Jaffrès PA, Ouldamer L, Maheo K, Fromont G, Potier-Cartereau M, Bougnoux P, Chantôme A, Vandier C. Papin M, et al. Among authors: gueguinou m. J Lipid Res. 2024 May;65(5):100544. doi: 10.1016/j.jlr.2024.100544. Epub 2024 Apr 18. J Lipid Res. 2024. PMID: 38642894 Free PMC article.
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. Proteau S, et al. Among authors: gueguinou m. EMBO Mol Med. 2023 Dec 7;15(12):e17719. doi: 10.15252/emmm.202317719. Epub 2023 Nov 15. EMBO Mol Med. 2023. PMID: 37966164 Free PMC article.
SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?
Dupuy M, Gueguinou M, Potier-Cartereau M, Lézot F, Papin M, Chantôme A, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: gueguinou m. Biochem Pharmacol. 2023 Oct;216:115774. doi: 10.1016/j.bcp.2023.115774. Epub 2023 Sep 5. Biochem Pharmacol. 2023. PMID: 37678626 Free article. Review.
43 results